Background Knowledge about and identification of T cell tumor antigens may inform the
development of T cell receptor-engineered adoptive cell transfer or personalized cancer vaccine …

Activation of antigen-specific T-lymphocyte responses may be needed to cure disorders
caused by chronic infection with low-risk human papillomavirus (lrHPV). Safe and effective …

Background As heterogeneous tumors develop in the face of intact immunity, tumor cells
harboring genomic or expression defects that favor evasion from T-cell detection or elimination …

Objective Organ preservation (OP) treatment for advanced laryngeal cancer has increased
compared to primary total laryngectomy. Our study compares oncologic and functional …

Background Most current approved or investigational immunotherapeutic approaches for
head and neck squamous cell carcinoma are aimed at activating T cells. The majority of …

Background/Aim: To assess factors that predict detection of tumors and oncologic outcomes
in head and neck squamous cell carcinoma of unknown primary (SCCUP). Patients and …

Introduction Auditory Neuropathy Spectrum Disorder (ANSD) is characterized by hearing
loss ranging from normal to profound. Additionally, results are confounded by commonly …

Owing to the presence of known tumor-specific viral antigens, human papillomavirus (HPV)-associated
cancers are well suited for treatment with immunotherapy designed to unleash, …

… Author links open overlay panel Maxwell Y. Lee BS a , Zi Ouyang PhD b , Danielle LaHurd
PhD b , Ping Xia PhD b , Samuel T. Chao MD b , John H. Suh MD b , Lilyana Angelov MD b c …

Background Predictive models to forecast the likelihood of specific outcomes after surgical
intervention allow informed shared decision‐making by surgeons and patients. Previous …